Details

Also available:      

Published: 13 June 2019

International Master-class "Innovation in Urology: (Conservative and Operational Approaches)". June 20-21, 2019, Almaty, Kazakhstan

NGO "Men's Health", Faculty of Medicine and Health KazNU them. Al-Farabi, AUA and the Endourological Society of WorldEndo Iniciative (USA) has the honor to invite you to take part in a master class on the theme: "Innovation in Urology: (Conservative and Operational Approaches)", which will be held in Almaty from June 20 to 21, 2019.

Organizers master class

• Public Association "Men's Health"
• Faculty of Medicine and Health KazNU named after Al-Farabi
• American Association of Urology (AUA)

Registration of participants:

  June 20, 2019 from 08:00-09:00

Venue: Almaty, 42 Timiryazev street, «Best Western Plus Atakent Park Hotel», small conference hall

Program of the master class

Contacts

+77017220991  +77772104328  +77019810998

  This email address is being protected from spambots. You need JavaScript enabled to view it.    This email address is being protected from spambots. You need JavaScript enabled to view it.

Details

Also available:      

Published: 22 June 2018

Dear colleagues!

In Urology of Kazakhstan is extremely important event!

June 14-15, 2018 in Almaty will organized a Kazakhstan - American master class "Minimally invasive and conservative Urology today". Main guest and participant John Denstedt is the general secretary of the American Association of Urology (AUA) PhD, MD, FRCSC, FACS, FCAHS professor.

Today Urology in the USA occupies the leading position in the world. The newest technologies of analysis, diagnosis and treatment in this field of medicine, which were developed and implemented in the world practice by Mr. Denstedt and his colleagues, can raise the effectiveness of therapy of urological patients in Kazakhstan.

The leading urologists of Kazakhstan, Russia, Uzbekistan, Georgia, Azerbaijan, Turkmenistan, Kyrgyzstan showed great interest in this event, and they will participate in the master class. The master class will last 2 days.

The first day is the methods of endoscopic intervention, indications and contraindications for various types of endoscopy (rigid, flexible).

The second day is percutaneous nephrolithotripsy. There will be demonstrated the approach for crushing stones by penetrating the skin directly into the kidney with a puncture needle and then crushing the stone with a laser or ultrasound.

It will be live surgery. For the first half of day theoretical issues will be considered. In the afternoon from 14.00 hours will be the practical implementation of the operations by the famous professor in the world with the broadcast to the conference room.

Physicians of various specialties are invited.

The venue of the master class: Almaty city, Al-Farabi Ave. No.71, Library of KazNU named after Al-Farabi, 4th floor, conference room.

Details by phone:

Aidos Sakenuly, tel .: +7 702 958-79-07; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.;

Yerlan Konyrov, tel.: +7 701 651-51-11; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it..

Details

Published: 22 June 2018

Modern methods of treatment of chronic bacterial prostatitis complicated by copulatory and fertile dysfunction: Methodological recommendations / Shalekenov B.U., Khusainov T.E., Kuandykov E.A. // Almaty: JSC "Kazakh Medical University of Continuing Education", 2017. - 34 p.

Content

• Introduction;
• Erectile dysfunction;
• Drug description - TRANSERA [ТРАНСЕРА] and TRANSCHERA ACTIVE [ТРАНСЕРА АКТИВ];
• Clinical study: the effectiveness and safety of drug  administration “TRANSERA” in patients with chronic prostatitis complicated by copulatory and fertile dysfunction;
• The experience of using the drug “TRANSERA ACTIVE” in patients with psychogenic erectile dysfunction;
• Conclusion;
• References;
• Appendix – Tests

Click here to read the full article.

Details

Published: 22 June 2018

Shalekenov B.U., Kuandykov E.A.

THE IMPROVEMENT OF QUALITY OF LIFE USING ULTRA-LOW DOSES OF ANTIBODIES IN THE THERAPY OF BENIGN PROSTATIC HYPERPLASIA

Department of Urology, Andrology and Sexopathology (Head of the Department, Doctor of Medicine, Prof. Shalekenov B.)

Introduction. Benign prostatic hyperplasia (BPH) occurs in elderly men. According to the autopsy data, morphological signs of BPH are registered at the age of 40-50 years in approximately 25% of men, 50-60 years in 50%, 60-70 years in 65%, 70-80 years in 80% and 80-90 years - in 90% [1,2,3]. However, that clinical manifestations of the disease occur only in 25-50% of patients with microscopic or macroscopic signs of BPH, and among them only 50% of patients apply for medical care [4,5].

Click here to read the full article.